It is anticipated that there will be supply shortage of salbutamol inhalation solution 2.5mg/2.5mL (Ventolin Nebules) from November 2023 to August 2024. Salbutamol Cipla 2.5mg/2.5mL brand is also unavailable.
An unregistered product (PMS-SALBUTAMOL salbutamol sulphate inhalation solution, BP 1mg/1mL (2.5mg/2.5mL) (Canada)) has been approved for supply under Section 19A until 1 September 2024. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Further updates on availability are available on the TGA website: https://apps.tga.gov.au/prod/MSI/search/
This anticipated shortage does not apply to salbutamol inhalation solution 5mg/2.5mL (Ventolin Nebules) or inhalers containing salbutamol.
Read more in the update for health professionals by National Asthma Council Australia Clinical Executive Lead, Debbie Rigby.
